Effects of quercetin on blood pressure and endothelial function in subjects with a high CVD risk phenotype (clinical intervention study)
Not Applicable
- Conditions
- Metabolic Syndromoverweight/obesity, hypertension, dyslipidaemia
- Registration Number
- DRKS00000555
- Lead Sponsor
- niversität BonnIEL Ernährungsphysiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
overweight or obesity (BMI 25-35 kg/m2), abdominal fat distribution, elevated resting blood pressure (pre-hypertension, stadium 1 hypertension), elevated C-reactive protein (>2,0 mg/L), dyslipidemia
Exclusion Criteria
pregnancy, lactation, malabsorption syndromes,
abnormal thyroid function, abnormal kidney function,
secondary hypertension, liver diseases, heart failure, history of myocardial infarction, insulin-dependent diabetes mellitus, diabetes insipidus, chronic inflammatory diseases, intake of supplements (fatty acids, vitamin E, magnesium, flavonoids), alcohol abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method